🇺🇸 FDA
Patent

US 10214509

Amino-substituted heterocyclic derivatives as sodium channel inhibitors

granted A61PA61P25/02

Quick answer

US patent 10214509 (Amino-substituted heterocyclic derivatives as sodium channel inhibitors) held by Almirall, S.A. expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/02